首页> 美国卫生研究院文献>Mycobiology >Diversity and Bioactive Potential of Culturable Fungal Endophytes of Medicinal Shrub Berberis aristata DC.: A First Report
【2h】

Diversity and Bioactive Potential of Culturable Fungal Endophytes of Medicinal Shrub Berberis aristata DC.: A First Report

机译:药用灌木小ber草可培养真菌内生菌的多样性和生物活性潜力:首次报道

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Bioactive natural compounds, isolated from fungal endophytes, play a promising role in the search for novel drugs. They are an inspiring source for researchers due to their enormous structural diversity and complexity. During the present study fungal endophytes were isolated from a well-known medicinal shrub, Berberis aristata DC. and were explored for their antagonistic and antioxidant potential. B. aristata, an important medicinal shrub with remarkable pharmacological properties, is native to Northern Himalayan region. A total of 131 endophytic fungal isolates belonging to eighteen species and nine genera were obtained from three hundred and thirty surface sterilized segments of different tissues of B. aristata. The isolated fungi were classified on the basis of morphological and molecular analysis. Diversity and species richness was found to be higher in leaf tissues as compared to root and stem. Antibacterial activity demonstrated that the crude ethyl acetate extract of 80% isolates exhibited significant results against one or more bacterial pathogens. Ethyl acetate extract of Alternaria macrospora was found to have potential antibacterial activity. Significant antioxidant activity was also found in crude ethyl acetate extracts of Alternaria alternata and Aspergillus flavus. Similarly, antagonistic activity of the fungal endophytes revealed that all antagonists possessed inhibition potential against more than one fungal pathogen. This study is an important step towards tapping endophytic fungal diversity for bioactive metabolites which could be a step forward towards development of novel therapeutic agents.
机译:从真菌内生菌中分离出来的具有生物活性的天然化合物在寻找新药方面发挥着有希望的作用。由于其巨大的结构多样性和复杂性,它们是研究人员的鼓舞人心的资源。在本研究中,真菌内生菌是从一种著名的药用灌木小Ber小DC DC中分离出来的。并探讨了它们的拮抗和抗氧化潜力。 B. aristata是一种具有重要药理特性的重要药用灌木,原产于喜马拉雅北部地区。共有131个内生真菌分离物,属于18个物种和9个属,是从B. aristata的不同组织的330个表面灭菌段中获得的。根据形态和分子分析对分离的真菌进行分类。与根和茎相比,叶组织中的多样性和物种丰富度更高。抗菌活性表明,80%分离物的乙酸乙酯粗提物对一种或多种细菌病原体显示出显着结果。发现大链格孢的乙酸乙酯提取物具有潜在的抗菌活性。在链格孢和黄曲霉的乙酸乙酯粗提物中也发现了重要的抗氧化活性。同样,真菌内生菌的拮抗活性表明,所有拮抗剂都具有针对一种以上真菌病原体的抑制潜能。这项研究是为生物活性代谢物开发内生真菌多样性的重要一步,这可能是开发新型治疗剂的一步。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号